Intracellular signalling and cancer: complex pathways lead to multiple targets

被引:14
作者
Bell, HS [1 ]
Ryan, KM [1 ]
机构
[1] Canc Res UK, Beatson Labs, Beatson Inst Canc Res, Tumour Cell Death Lab, Glasgow G61 1BD, Lanark, Scotland
关键词
oncogenes; tumour suppressor genes; cell signalling; cancer progression; therapy;
D O I
10.1016/j.ejca.2004.10.022
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Normal cells proliferate, die and differentiate as and when they should for the proper functioning of any particular tissue type. These processes are governed by a complex series of intracellular pathways that have many internal checkpoints and safety nets. These ensuring a fine, but tight, balance on overall tissue growth and distribution. A series of key aberrations, resulting in the disruption of these intracellular pathways, can lead to the development of a malignancy. The nature of these alterations is often not only tumour-specific, but also different between individuals with the same tumour type. As a result, these pathways have to be carefully dissected and functionally assessed to identify valid targets with therapeutic potential in a wide range of tumour types. (C) 2004 Elsevier Ltd. All rights reserved.
引用
收藏
页码:206 / 215
页数:10
相关论文
共 105 条
  • [1] A role for Cdc42 in macrophage chemotaxis
    Allen, WE
    Zicha, D
    Ridley, AJ
    Jones, GE
    [J]. JOURNAL OF CELL BIOLOGY, 1998, 141 (05) : 1147 - 1157
  • [2] Critical upstream signals of cytochrome c release induced by a novel Bcl-2 inhibitor
    An, J
    Chen, YM
    Huang, ZW
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (18) : 19133 - 19140
  • [3] A role of the kinase mTOR in cellular transformation induced by the oncoproteins P3k and Akt
    Aoki, M
    Blazek, E
    Vogt, PK
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (01) : 136 - 141
  • [4] Aurelio ON, 1998, CANCER RES, V58, P2190
  • [5] Src-induced de-regulation of E-cadherin in colon cancer cells requires integrin signalling
    Avizienyte, E
    Wyke, AW
    Jones, RJ
    McLean, GW
    Westhoff, MA
    Brunton, VG
    Frame, MC
    [J]. NATURE CELL BIOLOGY, 2002, 4 (08) : 632 - 638
  • [6] Enhanced phosphorylation of p53 by ATN in response to DNA damage
    Banin, S
    Moyal, L
    Shieh, SY
    Taya, Y
    Anderson, CW
    Chessa, L
    Smorodinsky, NI
    Prives, C
    Reiss, Y
    Shiloh, Y
    Ziv, Y
    [J]. SCIENCE, 1998, 281 (5383) : 1674 - 1677
  • [7] Hypoxia-inducible factor-1 and oncogenic signalling
    Bárdos, JI
    Athcroft, M
    [J]. BIOESSAYS, 2004, 26 (03) : 262 - 269
  • [8] Combining the anti-EGFR agent gefitinib with chemotherapy in non-small-cell lung cancer: How do we go from INTACT to impact?
    Baselga, J
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (05) : 759 - 761
  • [9] p14ARF links the tumour suppressors RB and p53
    Bates, S
    Phillips, AC
    Clark, PA
    Stott, F
    Peters, G
    Ludwig, RL
    Vousden, KH
    [J]. NATURE, 1998, 395 (6698) : 124 - 125
  • [10] Life and death decisions by E2F-1
    Bell, LA
    Ryan, KM
    [J]. CELL DEATH AND DIFFERENTIATION, 2004, 11 (02) : 137 - 142